Literature DB >> 15055764

Characterization and application of monoclonal antibodies against human endothelin B receptor expressed in insect cells.

Tomohiro Yamaguchi1, Ikuyo Arimoto-Tahara, Yoshinori Fujiyoshi, Tomoko Doi.   

Abstract

Endothelin B receptor (ET(B)R) is a G protein-coupled receptor that mediates a variety of signals by binding to vasoconstrictive peptides, endothelins. Monoclonal antibodies were prepared against human ET(B)R using the full-length protein expressed in Sf9 cells. Five typical monoclonal antibodies were characterized further for their recognition. The epitopes for the 2A5, 9A3 and 21A1 antibodies were mapped within the N-terminal extracellular sequences, V71-I85 and E27-Q41, respectively, which differ between the human and mouse ET(B)Rs. All of these antibodies labeled cell surface ET(B)R expressed in COS cells, suggesting that their recognition sites exist in the extracellular domain. In addition, the immobilized antibodies could purify ET(B)R expressed in Sf9 cells to the majority under mild conditions. Thus, immunization with the recombinant full-length membrane protein provides a strategy to produce monoclonal antibodies recognizing the native protein.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15055764     DOI: 10.1023/b:bile.0000015428.68786.39

Source DB:  PubMed          Journal:  Biotechnol Lett        ISSN: 0141-5492            Impact factor:   2.461


  2 in total

1.  Generation and characterization of rendomab-B1, a monoclonal antibody displaying potent and specific antagonism of the human endothelin B receptor.

Authors:  Bertrand Allard; Anne Wijkhuisen; Aurélie Borrull; Frédérique Deshayes; Fabienne Priam; Patricia Lamourette; Frédéric Ducancel; Didier Boquet; Jean-Yves Couraud
Journal:  MAbs       Date:  2012-12-05       Impact factor: 5.857

2.  Human Cytomegalovirus Up-Regulates Endothelin Receptor Type B: Implication for Vasculopathies?

Authors:  Koon-Chu Yaiw; Abdul-Aleem Mohammad; Helena Costa; Chato Taher; Sigrun Badrnya; Alice Assinger; Vanessa Wilhelmi; Sharan Ananthaseshan; Atosa Estekizadeh; Belghis Davoudi; Olga Ovchinnikova; Eugene Shlyakhto; Arnar Rafnsson; Zahidul Khan; Lynn Butler; Afsar Rahbar; John Pernow; Cecilia Söderberg-Nauclér
Journal:  Open Forum Infect Dis       Date:  2015-12-24       Impact factor: 3.835

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.